Similar articles for PMID: 31806771

Year	Number of Results
1999	2
2002	1
2003	2
2005	2
2006	1
2007	2
2008	4
2009	4
2010	1
2011	4
2012	2
2013	7
2014	3
2015	9
2016	9
2017	13
2018	17
2019	16
2020	5
2021	8
2022	4

1

Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for ¹⁸F-FDG Imaging of PSMA-Suppressed Tumors.

Bakht MK, Lovnicki JM, Tubman J, Stringer KF, Chiaramonte J, Reynolds MR, Derecichei I, Ferraiuolo RM, Fifield BA, Lubanska D, Oh SW, Cheon GJ, Kwak C, Jeong CW, Kang KW, Trant JF, Morrissey C, Coleman IM, Wang Y, Ahmadzadehfar H, Dong X, Porter LA. Bakht MK, et al. J Nucl Med. 2020 Jun;61(6):904-910. doi: 10.2967/jnumed.119.231068. Epub 2019 Dec 5. J Nucl Med. 2020. PMID: 31806771 Free PMC article.

2

A comparative study of peptide-based imaging agents [⁶⁸Ga]Ga-PSMA-11, [⁶⁸Ga]Ga-AMBA, [⁶⁸Ga]Ga-NODAGA-RGD and [⁶⁸Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models.

Zhang-Yin J, Provost C, Cancel-Tassin G, Rusu T, Penent M, Radulescu C, Comperat E, Cussenot O, Montravers F, Renard-Penna R, Talbot JN, Prignon A. Zhang-Yin J, et al. Nucl Med Biol. 2020 May-Jun;84-85:88-95. doi: 10.1016/j.nucmedbio.2020.03.005. Epub 2020 Mar 30. Nucl Med Biol. 2020. PMID: 32251995 Free article.

3

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

4

GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.

White MA, Tsouko E, Lin C, Rajapakshe K, Spencer JM, Wilkenfeld SR, Vakili SS, Pulliam TL, Awad D, Nikolos F, Katreddy RR, Kaipparettu BA, Sreekumar A, Zhang X, Cheung E, Coarfa C, Frigo DE. White MA, et al. Endocr Relat Cancer. 2018 Apr;25(4):453-469. doi: 10.1530/ERC-17-0051. Epub 2018 Feb 5. Endocr Relat Cancer. 2018. PMID: 29431615 Free PMC article.

5

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells.

Sommer U, Siciliano T, Ebersbach C, Beier AK, Stope MB, Jöhrens K, Baretton GB, Borkowetz A, Thomas C, Erb HHH. Sommer U, et al. Int J Mol Sci. 2022 Jan 18;23(3):1046. doi: 10.3390/ijms23031046. Int J Mol Sci. 2022. PMID: 35162969 Free PMC article.

6

Preclinical Evaluation and Pilot Clinical Study of Al¹⁸F-PSMA-BCH for Prostate Cancer PET Imaging.

Liu T, Liu C, Xu X, Liu F, Guo X, Li N, Wang X, Yang J, Yang X, Zhu H, Yang Z. Liu T, et al. J Nucl Med. 2019 Sep;60(9):1284-1292. doi: 10.2967/jnumed.118.221671. Epub 2019 Feb 22. J Nucl Med. 2019. PMID: 30796170 Free article.

7

A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.

Ganguly T, Dannoon S, Hopkins MR, Murphy S, Cahaya H, Blecha JE, Jivan S, Drake CR, Barinka C, Jones EF, VanBrocklin HF, Berkman CE. Ganguly T, et al. Nucl Med Biol. 2015 Oct;42(10):780-7. doi: 10.1016/j.nucmedbio.2015.06.003. Epub 2015 Jun 9. Nucl Med Biol. 2015. PMID: 26169882 Free PMC article.

8

Preclinical Evaluation of ¹⁸F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging.

Cardinale J, Schäfer M, Benešová M, Bauder-Wüst U, Leotta K, Eder M, Neels OC, Haberkorn U, Giesel FL, Kopka K. Cardinale J, et al. J Nucl Med. 2017 Mar;58(3):425-431. doi: 10.2967/jnumed.116.181768. Epub 2016 Oct 27. J Nucl Med. 2017. PMID: 27789722 Free article.

9

Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.

Bahler CD, Johnson MM, Davicioni E, Zhang J, Cheng L, Green MA, Koch MO. Bahler CD, et al. Urology. 2020 Oct;144:117-122. doi: 10.1016/j.urology.2020.06.025. Epub 2020 Jun 30. Urology. 2020. PMID: 32619596

10

The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor.

Kuroda K, Liu H. Kuroda K, et al. Int J Oncol. 2019 Apr;54(4):1357-1366. doi: 10.3892/ijo.2019.4706. Epub 2019 Feb 1. Int J Oncol. 2019. PMID: 30720063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed